Cardiovascular risk

Ritzel, PD Dr. R., Munich, Germany
Visceral adipositas: strategies to counteract
Wilding, Prof. J., Liverpool, United Kingdom
Sleep-disordered breathing and cardio-metabolic disease
Tuomilehto, Prof. J., Helsinki, Finland
Genome-wide association data and CV risk
Szucs, Prof. Dr. Thomas, University of Zurich, Zurich, Switzerland
Clinical benefit of point-of-care testing of cardiovascular biomarkers in acute coronary syndromes, heart failure and thromboembolic events in primary care(Archiv)
02-Sep-08
Gaziano, Dr. J. M., Boston, United States
Anti-platelet therapy across the the range of CV risk(Archiv)
30-Aug-08
Standl, Prof. E., Munich, Germany
Hyperglycemia and CV risk – recommendations from current guidelines(Archiv)
30-Aug-08
Ruilope, Prof. L. M., Madrid, Spain
CV risk – suggestions for a comprehensive CV risk management?(Archiv)
30-Aug-08
Tendera, Prof. M., Katowice, Poland
Summary and closing remarks(Archiv)
30-Aug-08
Tuomilehto, Prof. J., Helsinki, Finland
CV risk – an increasing global burden – how to find people at risk?(Archiv)
30-Aug-08
Lewanczuk, Dr. R., Alberta, Canada
Reducing the CV risk by anti-hypertensive combination strategies(Archiv)
30-Aug-08
Gaziano, Dr. J. M., Boston, United States
Case studies(Archiv)
30-Aug-08